A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is application/pdf
.
Engineered Muscle Tissues for Disease Modeling and Drug Screening Applications
2017
Current pharmaceutical design
J. Ramón-Azcón) and m.radisic@utoronto.ca (M. Radisic). † These authors contributed equally to this work. Abstract Animal models have been the main resources for drug discovery and prediction of drugs' pharmacokinetic responses in the body. However, noticeable drawbacks associated with animal models include high cost, low reproducibility, low physiological similarity to humans, and ethical problems. Engineered tissue models have recently emerged as an alternative or substitute for animal models
doi:10.2174/1381612823666170215115445
pmid:28215153
fatcat:ipfadaqjfzejbetvmwkik6rtkq